7 products in biotech. See what's launching and how each product is growing.
Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long
Public company listing
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell
Public company listing
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune sys
Public company listing
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes
Public company listing
Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery p
Public company listing
Velorum Therapeutics is a biotechnology company based in San Francisco, CA, that specializes in the development of novel medicines. The startup distinguishes itself by focusing on the biology of heme,
Public company listing
Yemaachi Biotechnology is a biotechnology startup focused on diversifying precision oncology by leveraging the genetic diversity of African populations. The company collects and sequences cancer sampl
Public company listing